Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001235802-23-000040)

Filing Details

Accession Number:: 0001235802-23-000040
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-04-11 17:40:11
Reporting Period:: 2023-04-10

Accepted Time:: 2023-04-11 17:40:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401040	Diamedica Therapeutics Inc.	DMAC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1971798	J. David Wambeke	301 Carlson Parkway, Suite 210 Minneapolis MN 55305	Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Voting Common Shares, No Par Value Per Share	Acquisiton	2023-04-10	468,750	$1.60	468,750	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Stock Option (right to buy)	Acquisiton	2023-04-10	140,000	$0.00	140,000	$1.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
140,000		2033-04-09	No	4	A	Direct

Footnotes

This option vests with respect to 35,000 common shares on April 10, 2024 and with respect to the remaining 75% of the common shares in 12 as nearly equal as possible quarterly installments commencing three months after the one-year anniversary of the grant date.